Cargando…
Limited Efficacy of α-Conopeptides, Vc1.1 and RgIA, To Inhibit Sensory Neuron Ca(V) Current1,2,3
Chronic pain is very difficult to treat. Thus, novel analgesics are a critical area of research. Strong preclinical evidence supports the analgesic effects of α-conopeptides, Vc1.1 and RgIA, which block α9α10 nicotinic acetylcholine receptors (nAChRs). However, the analgesic mechanism is controversi...
Autores principales: | Wright, Andrew B., Norimatsu, Yohei, McIntosh, J. Michael, Elmslie, Keith S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Neuroscience
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465272/ https://www.ncbi.nlm.nih.gov/pubmed/26078999 http://dx.doi.org/10.1523/ENEURO.0057-14.2015 |
Ejemplares similares
-
Conopeptides [V11L;V16D]ArIB and RgIA4: Powerful Tools for the Identification of Novel Nicotinic Acetylcholine Receptors in Monocytes
por: Grau, Veronika, et al.
Publicado: (2019) -
RgIA4 Accelerates Recovery from Paclitaxel-Induced Neuropathic Pain in Rats
por: Huynh, Peter N., et al.
Publicado: (2019) -
Cy3-RgIA-5727 Labels and Inhibits α9-Containing nAChRs of Cochlear Hair Cells
por: Fisher, Fernando, et al.
Publicado: (2021) -
RgIA4 Prevention of Acute Oxaliplatin-Induced Cold Allodynia Requires α9-Containing Nicotinic Acetylcholine Receptors and CD3(+) T-Cells
por: Huynh, Peter N., et al.
Publicado: (2022) -
Crystal Structure of the Monomeric Extracellular Domain of α9 Nicotinic Receptor Subunit in Complex With α-Conotoxin RgIA: Molecular Dynamics Insights Into RgIA Binding to α9α10 Nicotinic Receptors
por: Zouridakis, Marios, et al.
Publicado: (2019)